These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 34933583)

  • 1. Dupilumab facial redness: histologic characterization on a series of four cases.
    Dybała A; Sernicola A; Gomes V; Carnicelli G; Muharremi R; Grieco T
    Immunotherapy; 2022 Mar; 14(4):183-188. PubMed ID: 34933583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facial and neck erythema associated with dupilumab treatment: A systematic review.
    Jo CE; Finstad A; Georgakopoulos JR; Piguet V; Yeung J; Drucker AM
    J Am Acad Dermatol; 2021 May; 84(5):1339-1347. PubMed ID: 33428978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dupilumab facial redness: Clinical characteristics and proposed treatment in a cohort.
    Ordóñez-Rubiano MF; Casas M; Balaguera-Orjuela V
    Dermatol Ther; 2021 Nov; 34(6):e15140. PubMed ID: 34549488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Facial erythema in patients with atopic dermatitis treated with Dupilumab - a descriptive study of morphology and Aetiology.
    Ahn J; Lee DH; Na CH; Shim DH; Choi YS; Jung HJ; Simpson EL
    J Eur Acad Dermatol Venereol; 2022 Nov; 36(11):2140-2152. PubMed ID: 35695074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and histopathological characterization of paradoxical head and neck erythema in patients with atopic dermatitis treated with dupilumab: a case series.
    de Wijs LEM; Nguyen NT; Kunkeler ACM; Nijsten T; Damman J; Hijnen DJ
    Br J Dermatol; 2020 Oct; 183(4):745-749. PubMed ID: 31749159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Observation of the clinical features of dupilumab-associated facial erythema.
    Wu H; Zhang W; Wu Z; Shen Y; Zhang L; Yang M; Ren Y; Mao F
    Postepy Dermatol Alergol; 2023 Dec; 40(6):741-746. PubMed ID: 38282880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosomes derived from human adipose tissue-derived mesenchymal stem cells for the treatment of dupilumab-related facial redness in patients with atopic dermatitis: A report of two cases.
    Park KY; Han HS; Park JW; Kwon HH; Park GH; Seo SJ
    J Cosmet Dermatol; 2022 Feb; 21(2):844-849. PubMed ID: 33844417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of dupilumab in patients with atopic dermatitis: expert opinion.
    Francuzik W; Alexiou A; Worm M
    Expert Opin Drug Saf; 2021 Sep; 20(9):997-1004. PubMed ID: 34114910
    [No Abstract]   [Full Text] [Related]  

  • 9. Two differing presentations of periocular dermatitis as a side effect of dupilumab for atopic dermatitis.
    Yamane MLM; Belsito DV; Glass LRD
    Orbit; 2019 Oct; 38(5):390-394. PubMed ID: 30628518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevation of peripheral blood eosinophils during dupilumab treatment for atopic dermatitis is associated with baseline comorbidities and development of facial redness dermatitis and ocular surface disease.
    Ferrucci S; Angileri L; Tavecchio S; Fumagalli S; Iurlo A; Cattaneo D; Marzano AV; Maronese CA
    J Dermatolog Treat; 2022 Aug; 33(5):2587-2592. PubMed ID: 35261333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dupilumab Facial Redness/Dupilumab Facial Dermatitis: A Guide for Clinicians.
    Muzumdar S; Skudalski L; Sharp K; Waldman RA
    Am J Clin Dermatol; 2022 Jan; 23(1):61-67. PubMed ID: 34855151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angioedema: A potential complication of dupilumab in atopic dermatitis.
    Fritz AL; Lacy FA; Morrell DS
    Pediatr Dermatol; 2021 Jan; 38(1):237-238. PubMed ID: 33099796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New-onset head and neck dermatitis in adolescent patients after dupilumab therapy for atopic dermatitis.
    Bax CE; Khurana MC; Treat JR; Castelo-Soccio L; Rubin AI; McMahon PJ
    Pediatr Dermatol; 2021 Mar; 38(2):390-394. PubMed ID: 33426747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rosacea associated with dupilumab therapy.
    Heibel HD; Hendricks AJ; Foshee JP; Shi VY
    J Dermatolog Treat; 2021 Feb; 32(1):114-116. PubMed ID: 31132923
    [No Abstract]   [Full Text] [Related]  

  • 15. Dupilumab-associated cutaneous adverse events among adult patients with atopic dermatitis: A retrospective study.
    Napolitano M; Fabbrocini G; Patruno C
    J Dermatol; 2023 Jul; 50(7):880-887. PubMed ID: 36914982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weight gain in patients with severe atopic dermatitis treated with dupilumab: a cohort study.
    Johansson EK; Ivert LU; Bradley B; Lundqvist M; Bradley M
    BMC Dermatol; 2020 Sep; 20(1):8. PubMed ID: 32962676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acral erythema arising in patients with atopic dermatitis after dupilumab therapy: A case report of 3 patients.
    Kim YJ; Lee MY; Won CH
    Asia Pac Allergy; 2022 Jan; 12(1):e1. PubMed ID: 35174052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dupilumab after the 2017 approval for the treatment of atopic dermatitis: what's new and what's next?
    van der Schaft J; Thijs JL; de Bruin-Weller MS; Balak DMW
    Curr Opin Allergy Clin Immunol; 2019 Aug; 19(4):341-349. PubMed ID: 31145194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psoriasiform dermatitis during dupilumab treatment for moderate-to-severe atopic dermatitis in children.
    Parker JJ; Sugarman JL; Silverberg NB; Gonzalez ME; Ramien ML; Teng JMC; Paller AS
    Pediatr Dermatol; 2021 Nov; 38(6):1500-1505. PubMed ID: 34647354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allergic contact dermatitis to Compositae: A possible cause of dupilumab-associated facial and neck dermatitis in atopic dermatitis patients?
    Napolitano M; Fabbrocini G; Patruno C
    Contact Dermatitis; 2021 Oct; 85(4):473-474. PubMed ID: 33988858
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.